全文获取类型
收费全文 | 467篇 |
免费 | 21篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 42篇 |
妇产科学 | 1篇 |
基础医学 | 25篇 |
口腔科学 | 9篇 |
临床医学 | 47篇 |
内科学 | 91篇 |
皮肤病学 | 8篇 |
神经病学 | 12篇 |
特种医学 | 120篇 |
外科学 | 28篇 |
综合类 | 29篇 |
预防医学 | 14篇 |
眼科学 | 27篇 |
药学 | 30篇 |
肿瘤学 | 26篇 |
出版年
2023年 | 1篇 |
2020年 | 1篇 |
2019年 | 3篇 |
2018年 | 6篇 |
2017年 | 4篇 |
2016年 | 3篇 |
2015年 | 10篇 |
2014年 | 11篇 |
2013年 | 12篇 |
2012年 | 7篇 |
2011年 | 13篇 |
2010年 | 14篇 |
2009年 | 16篇 |
2008年 | 14篇 |
2007年 | 23篇 |
2006年 | 29篇 |
2005年 | 8篇 |
2004年 | 16篇 |
2003年 | 12篇 |
2002年 | 11篇 |
2001年 | 19篇 |
2000年 | 8篇 |
1999年 | 7篇 |
1998年 | 33篇 |
1997年 | 22篇 |
1996年 | 28篇 |
1995年 | 22篇 |
1994年 | 19篇 |
1993年 | 22篇 |
1992年 | 7篇 |
1991年 | 5篇 |
1990年 | 9篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 13篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1975年 | 1篇 |
排序方式: 共有510条查询结果,搜索用时 0 毫秒
61.
Alterations in neutrophil subpopulations during human hemodialysis or following injection of C5a des arg into rabbits were studied. Whereas baseline peripheral blood neutrophils contained approximately 80% of cells that formed rosettes with IgG-sensitized erythrocytes, neutrophils harvested at the granulocyte nadir (20 min after initiating hemodialysis or the injection of C5a des arg) were markedly depleted of this population. This was seen in a change in ratio of rosette-forming neutrophils (RFN) to non-rosette-forming neutrophils (non-RFN) from 4:1 at 0 time to 1:2 at 20 min. Since non-RFN are less active in assays of adherence and chemotaxis, these alterations in circulating neutrophil populations were reflected in abnormal functional capacity of neutrophils harvested at 20 min. To study the mechanism of RFN depletion, we investigated the ability of C5a des arg to aggregate various human neutrophil suspensions. Unfractionated neutrophils and RFN demonstrated prompt in vitro aggregation in response to C5a des arg, whereas this activated complement fragment induced little aggregation in a population enriched for non-RFN. These results may explain the alterations in neutrophil adherence, chemotaxis, phagocytosis, and bactericidal activity, which have been reported to accompany clinical disorders characterized by in vivo complement activation (i.e., hemodialysis or gram-negative sepsis). 相似文献
62.
Gerdes VE ten Cate H de Groot E Kwa VI Prins MH Reitsma PH Büller HR Brandjes DP;Amsterdam Vascular Medicine Group 《Atherosclerosis》2002,163(1):135-140
The G20210A mutation in the prothrombin gene is an established risk factor for venous thrombosis. There is controversy about the role of this mutation in arterial thrombotic disease and atherosclerosis. We determined the presence of the prothrombin mutation and examined its influence on carotid and femoral artery intima-media thickness (IMT) and the occurrence of new ischemic events during follow-up in 277 patients with clinically manifest atherosclerotic disease: ischemic stroke, myocardial infarction or peripheral arterial disease. The mean age at entry was 63 years. Mean IMT was significantly higher in carriers of the prothrombin mutation (1.17 (SD 0.29) mm versus 0.97 (SD 0.25) mm: (delta)IMT=0.20, P=0.02). The increase in IMT was not attributable to differences in age, type of arterial disease or cardiovascular risk factors between carriers and non-carriers. During a mean follow-up of 3.5 years, a strong trend for more ischemic events was observed: 4 of the 11 carriers suffered from a recurrent ischemic event, compared with 30 of the 164 male non-carriers (36 versus 18%; P=0.06). These results suggest that the G20210A mutation contributes to the process of arterial wall thickening and is associated with the occurrence of ischemic events in a cohort of elderly persons with established atherosclerosis. 相似文献
63.
CH Reynolds BBSc DP Crewther PhD SG Crewther PhD SJ West BSc 《Clinical & experimental ophthalmology》1998,26(S1):S117-S119
64.
65.
A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use 总被引:9,自引:0,他引:9
Kenny T; Wilson RG; Purves IN; Clark J Sr; Newton LD; Newton DP; Moseley DV 《Family practice》1998,15(5):471-479
This article reviews the usefulness and importance of written information,
specifically leaflets, being given to patients. Evidence suggesting how
both patient and doctor may benefit from the giving of written information
is reviewed. Identification of good practice relating to the content and
readability of leaflets is discussed. An argument is put forward that the
giving of written information is an under-utilized resource in contributing
to improving patient outcomes but that this may be changing with the
increasing use of patient leaflet databases. The advantages and
disadvantages of computer- generated patient leaflets are discussed and
desirable further areas of research on computer-generated leaflets are
proposed.
相似文献
66.
67.
Clinical experience with an endobronchial implant 总被引:1,自引:0,他引:1
68.
69.
70.
Edwin J. R. van Beek B. Ed Schenk Bowine C. Michel Bram van den Ende Dees P. M. Brandjes Yvonne T. van der Heide Patrick M. M. Bossuyt & Harry R. Büller 《British journal of haematology》1996,92(3):725-732
Objective . To determine the role of four ELISA D-dimer assays in the exclusion of pulmonary embolism.
Design . Blinded comparison using pulmonary angiography and/or lung scintigraphy as a reference method.
Setting . A secondary and tertiary referral centre.
Patients and methods . Consecutive patients with suspected pulmonary embolism underwent lung scintigraphy, followed by angiography if a non-diagnostic result was obtained. Comorbid conditions resulting in elevated plasma D-dimer levels were defined a priori . Cut-off levels for 100% sensitivity were determined. A decision-analytic model was used to determine effectiveness and costs in the management pulmonary embolism.
Main outcome measures . The exclusion efficacy of the various assays at a sensitivity of 100%, and cost-effectiveness.
Results . A total of 179 patients were included (78 inpatients and 101 outpatients; 74 patients had comorbid conditions). Pulmonary embolism could be adequately excluded in between 8% and 18% of all patients, and in between 3% and 7% and 11% and 27% of inpatients and outpatients, respectively, depending on the assay used. D-dimer assays could exclude pulmonary embolism in <5% of patients with comorbid conditions, whereas this increased to 14–32% in outpatients without comorbid conditions. A cost-effectiveness analysis showed a cost reduction of 10% at a specificity of 30%, largely due to a 28% decrease in angiography requirements. Furthermore, for every 2% decrease in sensitivity, one per 1000 evaluated patients would die as a result of inadequately treated pulmonary embolism.
Conclusion . D-dimer ELISA assays may have a role in the exclusion of pulmonary embolism in symptomatic outpatients, where the application may reduce angiography by 30% and costs by 10%. 相似文献
Design . Blinded comparison using pulmonary angiography and/or lung scintigraphy as a reference method.
Setting . A secondary and tertiary referral centre.
Patients and methods . Consecutive patients with suspected pulmonary embolism underwent lung scintigraphy, followed by angiography if a non-diagnostic result was obtained. Comorbid conditions resulting in elevated plasma D-dimer levels were defined a priori . Cut-off levels for 100% sensitivity were determined. A decision-analytic model was used to determine effectiveness and costs in the management pulmonary embolism.
Main outcome measures . The exclusion efficacy of the various assays at a sensitivity of 100%, and cost-effectiveness.
Results . A total of 179 patients were included (78 inpatients and 101 outpatients; 74 patients had comorbid conditions). Pulmonary embolism could be adequately excluded in between 8% and 18% of all patients, and in between 3% and 7% and 11% and 27% of inpatients and outpatients, respectively, depending on the assay used. D-dimer assays could exclude pulmonary embolism in <5% of patients with comorbid conditions, whereas this increased to 14–32% in outpatients without comorbid conditions. A cost-effectiveness analysis showed a cost reduction of 10% at a specificity of 30%, largely due to a 28% decrease in angiography requirements. Furthermore, for every 2% decrease in sensitivity, one per 1000 evaluated patients would die as a result of inadequately treated pulmonary embolism.
Conclusion . D-dimer ELISA assays may have a role in the exclusion of pulmonary embolism in symptomatic outpatients, where the application may reduce angiography by 30% and costs by 10%. 相似文献